• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤抑制因子p53在抗氧化防御和代谢中的作用。

The role of tumor suppressor p53 in the antioxidant defense and metabolism.

作者信息

Budanov Andrei V

机构信息

Department of Neurosurgery & Biochemistry and Molecular Biology, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA,

出版信息

Subcell Biochem. 2014;85:337-58. doi: 10.1007/978-94-017-9211-0_18.

DOI:10.1007/978-94-017-9211-0_18
PMID:25201203
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4206257/
Abstract

Tumor suppressor p53 is inactivated in most cancers and the critical role of p53 in the suppression of carcinogenesis has been confirmed in many mouse models. The protein product of the tumor suppressor p53 gene works as a transcriptional regulator, activating expression of numerous genes involved in cell death, cell cycle arrest, senescence, DNA-repair and many other processes. In spite of the multiple efforts to characterize the functions of p53, the mechanisms of tumor suppression by p53 are still elusive. Recently, new activities of p53 such as regulation of reactive oxygen species (ROS) and metabolism have been described and the p53-regulated genes responsible for these functions have been identified. Metabolic derangements and accumulation of ROS are features of carcinogenesis, supporting the idea that many tumor suppressive effects of p53 can be mediated by regulation of metabolism and/or ROS. Mutations in the p53 gene can not only inactivate wild type function of p53 but also endow p53 with new functions such as activation of new metabolic pathways contributing to carcinogenesis. Understanding the metabolic and antioxidant functions of p53 allows us to develop approaches to restore p53 function in cancers, where p53 is inactivated, in other to ensure the best outcome of anti-cancer treatment.

摘要

肿瘤抑制因子p53在大多数癌症中失活,并且p53在抑制肿瘤发生中的关键作用已在许多小鼠模型中得到证实。肿瘤抑制因子p53基因的蛋白质产物作为一种转录调节因子,激活众多参与细胞死亡、细胞周期停滞、衰老、DNA修复及许多其他过程的基因的表达。尽管人们为表征p53的功能付出了诸多努力,但p53抑制肿瘤的机制仍不清楚。最近,已描述了p53的新活性,如对活性氧(ROS)和代谢的调节,并且已鉴定出负责这些功能的p53调节基因。代谢紊乱和ROS积累是肿瘤发生的特征,这支持了p53的许多肿瘤抑制作用可通过调节代谢和/或ROS来介导的观点。p53基因中的突变不仅可使p53的野生型功能失活,还可赋予p53新功能,如激活有助于肿瘤发生的新代谢途径。了解p53的代谢和抗氧化功能使我们能够开发在p53失活的癌症中恢复p53功能的方法,以确保抗癌治疗取得最佳效果。

相似文献

1
The role of tumor suppressor p53 in the antioxidant defense and metabolism.肿瘤抑制因子p53在抗氧化防御和代谢中的作用。
Subcell Biochem. 2014;85:337-58. doi: 10.1007/978-94-017-9211-0_18.
2
Tumor suppressor genes and ROS: complex networks of interactions.肿瘤抑制基因与 ROS:相互作用的复杂网络。
Free Radic Biol Med. 2012 Jan 1;52(1):7-18. doi: 10.1016/j.freeradbiomed.2011.09.035. Epub 2011 Oct 6.
3
Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function.谷氨酰胺酶 2:一种新的 p53 靶基因,调节能量代谢和抗氧化功能。
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7455-60. doi: 10.1073/pnas.1001006107. Epub 2010 Apr 8.
4
The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense.尿酸转运蛋白SLC2A9是肿瘤抑制因子p53的直接靶基因,有助于抗氧化防御。
Oncogene. 2015 Apr 2;34(14):1799-810. doi: 10.1038/onc.2014.119. Epub 2014 May 26.
5
Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses.SAT1 的激活通过 p53 介导的铁死亡反应参与多胺代谢。
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6806-E6812. doi: 10.1073/pnas.1607152113. Epub 2016 Oct 3.
6
Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damage.端粒 DNA 诱导 p53 依赖性活性氧并防止氧化损伤。
J Dermatol Sci. 2009 Dec;56(3):154-62. doi: 10.1016/j.jdermsci.2009.08.008. Epub 2009 Nov 10.
7
Stress-responsive sestrins link p53 with redox regulation and mammalian target of rapamycin signaling.应激响应 sestrins 将 p53 与氧化还原调控和哺乳动物雷帕霉素靶蛋白信号联系起来。
Antioxid Redox Signal. 2011 Sep 15;15(6):1679-90. doi: 10.1089/ars.2010.3530. Epub 2011 Feb 18.
8
Influence of Tumor Suppressor p53 Functioning on the Expression of Antioxidant System Genes under the Action of Cytotoxic Compounds.抑癌基因 p53 功能对细胞毒性化合物作用下抗氧化系统基因表达的影响。
Bull Exp Biol Med. 2020 May;169(1):169-175. doi: 10.1007/s10517-020-04844-3. Epub 2020 Jun 5.
9
The dual role of p53: DNA protection and antioxidant.p53 的双重作用:DNA 保护和抗氧化。
Free Radic Res. 2011 Jun;45(6):643-52. doi: 10.3109/10715762.2011.571685. Epub 2011 Mar 31.
10
The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells.GTP 酶 KRAS 通过激活癌细胞中 NRF2 调节的抗氧化防御系统来抑制肿瘤抑制因子 p53。
J Biol Chem. 2020 Mar 6;295(10):3055-3063. doi: 10.1074/jbc.RA119.011930. Epub 2020 Jan 30.

引用本文的文献

1
Oxidative Stress-Driven Cellular Senescence: Mechanistic Crosstalk and Therapeutic Horizons.氧化应激驱动的细胞衰老:机制串扰与治疗前景
Antioxidants (Basel). 2025 Aug 12;14(8):987. doi: 10.3390/antiox14080987.
2
Suppressor effects of carrots on azoxymethane/dextran sulfate sodium-induced colon cancer according to cultivation method.根据种植方法研究胡萝卜对氧化偶氮甲烷/葡聚糖硫酸钠诱导的结肠癌的抑制作用。
Front Immunol. 2025 Apr 11;16:1554801. doi: 10.3389/fimmu.2025.1554801. eCollection 2025.
3
Unraveling the effects of uric acid on endothelial cells: A global proteomic study.解析尿酸对内皮细胞的影响:一项全蛋白质组学研究。
Redox Biol. 2025 May;82:103625. doi: 10.1016/j.redox.2025.103625. Epub 2025 Apr 1.
4
Exploiting somatic oncogenic driver alterations in a patient with Li-Fraumeni syndrome- paving the path towards precision medicine: a case report.利用李-弗劳梅尼综合征患者的体细胞致癌驱动基因改变——迈向精准医学之路:一例病例报告
J Cancer Res Clin Oncol. 2025 Jan 16;151(1):37. doi: 10.1007/s00432-024-06077-7.
5
Chronic kidney disease and aging: dissecting the p53/p21 pathway as a therapeutic target.慢性肾脏病与衰老:剖析p53/p21信号通路作为治疗靶点
Biogerontology. 2024 Dec 26;26(1):32. doi: 10.1007/s10522-024-10173-z.
6
Enhancing Gpx1 palmitoylation to inhibit angiogenesis by targeting PPT1.通过靶向 PPT1 增强 GPx1 的棕榈酰化以抑制血管生成。
Redox Biol. 2024 Nov;77:103376. doi: 10.1016/j.redox.2024.103376. Epub 2024 Oct 5.
7
8-Week Extract Administration Improves Submaximal Exercise Capacity in Mice by Enhancing Skeletal Muscle Antioxidant Gene Expression and Plasma Antioxidant Capacity.8周提取物给药通过增强骨骼肌抗氧化基因表达和血浆抗氧化能力提高小鼠亚极量运动能力。
Antioxidants (Basel). 2024 Sep 23;13(9):1147. doi: 10.3390/antiox13091147.
8
Assessment of the Circulating PD-1 and PD-L1 Levels and P53 Expression as a Predictor of Relapse in Pediatric Patients with Wilms Tumor and Hypernephroma.评估循环中程序性死亡受体1(PD-1)和程序性死亡配体1(PD-L1)水平以及P53表达作为肾母细胞瘤和肾细胞癌小儿患者复发预测指标的研究
Children (Basel). 2024 Aug 23;11(9):1035. doi: 10.3390/children11091035.
9
Unveiling the impact of glutathione (GSH) and gene deletion on tumor cell metabolism by amino acid and proteomics analysis.通过氨基酸和蛋白质组学分析揭示谷胱甘肽(GSH)和基因缺失对肿瘤细胞代谢的影响。
J Gastrointest Oncol. 2024 Jun 30;15(3):1002-1019. doi: 10.21037/jgo-24-236. Epub 2024 Jun 27.
10
Ubiquitin-specific protease 54 regulates GLUT1-mediated aerobic glycolysis to inhibit lung adenocarcinoma progression by modifying p53 degradation.泛素特异性蛋白酶 54 通过调节 GLUT1 介导的有氧糖酵解来抑制肺腺癌的进展,其方式为修饰 p53 的降解。
Oncogene. 2024 Jun;43(26):2025-2037. doi: 10.1038/s41388-024-03047-8. Epub 2024 May 14.

本文引用的文献

1
Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer.突变型 p53 延长 NF-κB 的激活,促进慢性炎症和炎症相关的结直肠癌。
Cancer Cell. 2013 May 13;23(5):634-46. doi: 10.1016/j.ccr.2013.03.022.
2
Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses.全球基因组分析揭示了广泛的 p53 调节的自噬程序,有助于关键的 p53 反应。
Genes Dev. 2013 May 1;27(9):1016-31. doi: 10.1101/gad.212282.112.
3
p53 induces transcriptional and translational programs to suppress cell proliferation and growth.p53诱导转录和翻译程序以抑制细胞增殖和生长。
Genome Biol. 2013 Apr 17;14(4):R32. doi: 10.1186/gb-2013-14-4-r32.
4
The B55α subunit of PP2A drives a p53-dependent metabolic adaptation to glutamine deprivation.PP2A 的 B55α 亚基驱动依赖于 p53 的代谢适应来应对谷氨酰胺缺乏。
Mol Cell. 2013 Apr 25;50(2):200-11. doi: 10.1016/j.molcel.2013.02.008. Epub 2013 Mar 14.
5
Increased oxidative metabolism in the Li-Fraumeni syndrome.李-佛美尼综合征中的氧化代谢增加。
N Engl J Med. 2013 Mar 14;368(11):1027-32. doi: 10.1056/NEJMoa1214091.
6
Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1.生长信号通过 mTOR 和 S6K1 刺激从头合成嘧啶。
Science. 2013 Mar 15;339(6125):1323-8. doi: 10.1126/science.1228792. Epub 2013 Feb 21.
7
The regulation of cellular metabolism by tumor suppressor p53.肿瘤抑制因子 p53 对细胞代谢的调节。
Cell Biosci. 2013 Feb 6;3(1):9. doi: 10.1186/2045-3701-3-9.
8
Sestrins activate Nrf2 by promoting p62-dependent autophagic degradation of Keap1 and prevent oxidative liver damage.Sestrins 通过促进 Keap1 依赖自噬的 p62 降解来激活 Nrf2,并预防氧化肝损伤。
Cell Metab. 2013 Jan 8;17(1):73-84. doi: 10.1016/j.cmet.2012.12.002. Epub 2012 Dec 27.
9
p53 mutations in cancer.癌症中的 p53 突变。
Nat Cell Biol. 2013 Jan;15(1):2-8. doi: 10.1038/ncb2641.
10
Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells.丝氨酸饥饿会诱导癌细胞产生应激和依赖 p53 的代谢重排。
Nature. 2013 Jan 24;493(7433):542-6. doi: 10.1038/nature11743. Epub 2012 Dec 16.